Trial on the Effect of Optically Modified Fiber Mattress Covers on Sleep Disturbances in Patients With Chronic Back Pain

Study Description

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Brief Summary:

Sleep quantity and quality can be influenced by the type of mattress used. This study is being done to see if a mattress cover with optically active particles can help back pain and improve sleep quality.

Condition or disease	Intervention/treatment	Phase
Back Pain; Insomnia	Device: Active Mattress Cover; Device: Placebo Mattress Cover	Not Applicable

Detailed Description:

It is commonly observed that sleep in its quantity and quality is influenced by the type of mattress used at night. A recent study in patients with back pain showed that waterbeds and foam mattresses did influence back symptoms, function and sleep more positively than did a hard mattress. Pain improves with airbeds compared to regular innerspring mattresses. This study will analyze the effect of optically active particles mattress covers on sleep. The researcher is interested in learning if regular mattress or the study mattress cover (containing optically modified polyethylene terephthalate fiber mattress cover) is more useful in helping back pain and sleep quality.

Study Design

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type :	Interventional (Clinical Trial)
Actual Enrollment :	8 participants
Allocation:	Randomized
Intervention Model:	Crossover Assignment
Masking:	Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:	Treatment
Official Title:	Double Blind, Placebo Controlled, Crossover Pilot Trial on the Effect of Optically Modified Polyethylene Terephthalate Fiber Mattress Covers on Sleep Disturbances in Patients With Chronic Back Pain
Study Start Date :	June 2009
Actual Primary Completion Date :	July 2011
Actual Study Completion Date :	July 2011

Arms and Interventions

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm	Intervention/treatment
Active Comparator: Active Mattress Cover; Subjects in this arm will be given the placebo mattress cover followed active mattress cover .	Device: Active Mattress Cover; Active Mattress Cover
Placebo Comparator: Placebo Mattress Cover; Subjects in this arm will be given the active mattress cover followed by the placebo mattress cover.	Device: Placebo Mattress Cover; Placebo Mattress Cover

Outcome Measures

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :

1. Optically Modified Polyethylene Terephthalate Fiber Mattress Cover (OMPETFMC) Improves Sleep Quality in Patients With Lower Back Pain as Measured by Clinical Global Impression (CGI). [ Time Frame: 14 days ]

   The primary outcomes are the change in mean daily Clinical Global Impressions (pain and sleep) in placebo mattress compared to active mattress cover (assessed daily for 14 days per intervention).

   The daily scores range from 1 (very much improved) to 7 (very much worse).

Secondary Outcome Measures :

1. Sleep Variables (Nighttime Wake-time) Measured With Actigraphy in Patients With Lower Back Pain. [ Time Frame: Assessed daily for 14 days per intervention. ]
   Secondary outcome: Nighttime wake-time after sleep onset with placebo mattress cover compared to active mattress cover.
2. Sleep Variables (Total Sleep) Measured With Actigraphy in Patients With Lower Back Pain. [ Time Frame: Assessed daily for 14 days per intervention. ]
   Secondary outcome: Total sleep time with placebo mattress cover compared to active mattress cover.
3. Sleep Variables (Nocturnal Awakenings) Measured With Actigraphy in Patients With Lower Back Pain. [ Time Frame: Assessed daily for 14 days per intervention. ]
   Secondary outcome: Number of nocturnal awakenings with placebo mattress cover compared to active mattress cover.
4. Sleep Variables (Sleep Efficiency) Measured With Actigraphy in Patients With Lower Back Pain. [ Time Frame: Assessed daily for 14 days per intervention. ]
   Secondary outcome: Sleep efficiency in placebo mattress cover compared to active mattress cover.
5. Sleep Variables (Sleep Latency) Measured With Actigraphy in Patients With Lower Back Pain. [ Time Frame: Assessed daily for 14 days per intervention. ]
   Secondary outcome: Sleep latency in placebo mattress cover compared to active mattress cover.

Eligibility Criteria

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Ages Eligible for Study:	18 Years and older (Adult, Senior)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

You are eligible to participate in this study if you:

1. have a clinical diagnosis of chronic lower back pain
2. have pain measured on the Visual Analogue scale
3. have sleep disturbances at night associated with chronic lower back pain
4. are 18 years or older
5. sign the written, informed consent form prior to the initiation of any study procedures
6. have an habitual bedtime between 8 P.M. and 12 A.M.
7. are on a stable pain management regime

Exclusion Criteria:

You are not eligible to participate in this study if you:

1. are unwilling or unable to comply with the protocol or scheduled appointments
2. are unable to understand the language in which the approved informed consent is written
3. have no pain measured on the Visual Analogue scale
4. are unable to walk, wheel chair bound or confined to bed
5. are deemed by the investigator to be unreliable to wear the actigraphy, to complete the sleep log, to use the provided mattress covers at the proper time, to come to the scheduled visits or to answer questions regarding the subject's condition or medication use
6. lack a mobile arm to which to attach an actigraphy.
7. are currently participate or participated in another clinical study within the past 30 days
8. demonstrate an unwillingness to comply with the maximum limit of two alcoholic drinks per day and only 1 alcoholic drink after 6:00 P.M. for the duration of the protocol
9. use tobacco products or any other products during nightly awakenings that may interfere with the sleep wake cycle
10. have any unstable medical condition as determined by the investigator, or any other serious disease or condition that might affect life expectancy or make it difficult to successfully manage and follow the subject according to the protocol

Contacts and Locations

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Locations

United States, California
UC Irvine-MDA ALS and Neuromuscular Center
Orange, California, United States, 92868

Sponsors and Collaborators

University of California, Irvine

Investigators

Principal Investigator:	Annabel K Wang, MD	UC Irvine

More Information

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Responsible Party:	Annabel Kim Wang, Associate Clinical Professor, University of California, Irvine
ClinicalTrials.gov Identifier:	NCT00969540 History of Changes
Other Study ID Numbers:	mattress1
First Posted:	September 1, 2009
Results First Posted:	December 3, 2014
Last Update Posted:	December 3, 2014
Last Verified:	December 2014

Keywords provided by Annabel Kim Wang, University of California, Irvine:

Back Pain; Sleep

Additional relevant MeSH terms:

Back Pain; Dyssomnias; Sleep Wake Disorders; Parasomnias; Pain	Neurologic Manifestations; Nervous System Diseases; Signs and Symptoms; Mental Disorders